Pipeline and Early Commercial Strategy Lead

About the Department 

Our Commercial Strategy and Marketing group creates and delivers human-centered experiences, where innovation meets customer-centricity, driving the ultimate experience for our patients. Our focus extends beyond transactions to craft experiences as one fully integrated, aligned and connected organization that puts empathy at the center, powered by insight and foresight.

We develop an end-to-end approach to strategy, focusing on every touchpoint that impacts our customers. We leverage data and insights to inform our decision-making processes, ensuring that our strategies are rooted in a deep understanding of customer needs and behaviors. Our 'test and learn’ mindset and approach enables us to iterate rapidly and refine our strategies based on real-world results.

We are building an intentional team culture that is made up of diverse skillsets, united by the shared belief that reinvention and learning is what fuels continuous growth. Do you get excited about exploring the unknown? Does the idea of driving value through human-centered design pull you in? Are you ready to experiment with us?

The Position

The Pipeline and Early Commercial Strategy Lead will be at the forefront of shaping the future of the Novo Nordisk portfolio by owning the commercial strategy for pharmaceutical assets in the early stages of development within the CS&M (Commercial Strategy and Marketing) organization. This role is responsible for developing commercialization strategies to maximize the value of assets and the enterprise as well as providing strategic input into clinical trial strategy and regulatory development. With a holistic overview across the pipeline portfolio, the Lead ensures alignment with business objectives and market needs. This role will focus on a time horizon of ~3+ years from commercialization (or commitment to phase 3 trials) and enable seamless product transition to launch teams.

Relationships

Reports to the Head of Commercial Portfolio Strategy, Pipeline, BD&L. Collaborates with cross-functional teams, including portfolio, marketing, medical, R&D, regulatory affairs, analytics, and other relevant NNI departments to define pipeline strategy, define early commercial strategy and transition to launch teams. This role will have a team of early product asset owners reporting into them.

Essential Functions

Physical Requirements

Approximately 20-30% overnight travel.

Development of People

Responsible for setting and communicating clear individualized role expectations for each report based on position, skills, talents, and objectives. Ensure that reporting personnel have strengths-based individual development plans (IDP), with annual goals and measurements that are consistent with the priorities of the business. Provide regular coaching of reports that prioritizes appropriate challenging, development, feedback, regular recognition, and support.

Qualifications

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.

Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.

If you are interested in applying to Novo Nordisk and need special assistance or an accommodation to apply, please call us at 1-855-411-5290. This contact is for accommodation requests only and cannot be used to inquire about the status of applications.